Skip to content

Opening book details…

About this Medicine article

Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long-term data from phase III clinical trials by Hughes, Derralynn A.; Gonzalez, Derlis E.; Lukina, Elena A.; Mehta, Atul; Kabra, Madhulika; Elstein, Deborah; Kisinovsky, Isaac; Giraldo, Pilar; Bavdekar, Ashish; Hangartner, Thomas N.; Wang, Nan; Crombez, Eric; Zimran, Ari is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Hughes, Derralynn A.; Gonzalez, Derlis E.; Lukina, Elena A.; Mehta, Atul; Kabra, Madhulika; Elstein, Deborah; Kisinovsky, Isaac; Giraldo, Pilar; Bavdekar, Ashish; Hangartner, Thomas N.; Wang, Nan; Crombez, Eric; Zimran, Ari
Publisher
John Wiley and Sons; Wiley (John Wiley & Sons); John Wiley & Sons Inc.; Wiley; Research Square (ISSN 0361-8609)
Published
2015
Language
EN
Field
Medicine (Health Sciences)

More by Hughes, Derralynn A.; Gonzalez, Derlis E.; Lukina, Elena A.; Mehta, Atul; Kabra, Madhulika; Elstein, Deborah; Kisinovsky, Isaac; Giraldo, Pilar; Bavdekar, Ashish; Hangartner, Thomas N.; Wang, Nan; Crombez, Eric; Zimran, Ari

Browse all works by Hughes, Derralynn A.; Gonzalez, Derlis E.; Lukina, Elena A.; Mehta, Atul; Kabra, Madhulika; Elstein, Deborah; Kisinovsky, Isaac; Giraldo, Pilar; Bavdekar, Ashish; Hangartner, Thomas N.; Wang, Nan; Crombez, Eric; Zimran, Ari